Delivery Order SPE2DB25D3110-SPE2DB25FTCXF

Award Date 3/31/25
Potential Completion Date 4/21/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $5,372.90 firm-fixed-price contract is for the delivery of "PROQUAD VIALS", a medical product, with a completion date of February 19, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for PROQUAD VIALS, a medical supply, with a firm fixed price ceiling value of $1,601.99. The contract has an ultimate completion date of October 4, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for $3,141.08. The order is for the supply of 4565980305 PROQUAD VIALS, a pharmaceutical product, with a completion date of October 21, 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,247.58, is for the delivery of PROQUAD VIALS and has an ultimate completion date of January 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Medical Troop Support to AmerisourceBergen Drug Corporation's Corporate Office division. The $4,159.95 firm fixed-price contract is for the delivery of PROQUAD VIALS, a pharmaceutical product. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded multiple Indefinite Delivery Contracts (IDCs) by federal agencies,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,601.99 firm fixed price contract is for the delivery of PROQUAD VIALS, a pharmaceutical product. The award has an ultimate completion date of August 23, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PROQUAD VIALS. The contract has a firm fixed price of $6,495.16 and a completion date of December 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,952.11, is for the delivery of PROQUAD VIALS, a pharmaceutical product. It is a firm fixed-price contract with an ultimate completion date of November 21, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,271.65, is for the delivery of PROQUAD VIALS, a type of medical product. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $77,787.60, is for the delivery of PROQUAD VIALS, a medical product. The contract does not have a set-aside designation, indicating open competition. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
  • SPE2DB25D3110
    Indefinite Delivery Contract
  • SPE2DB25D3110-SPE2DB25FTCXF
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,687.48, is for the procurement of PROQUAD VIALS, a medical product. The contract has no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 6/30/25, 11:06 AM